Data-driven Drug Discovery in Women’s Health & Reproductive Medicine
Discover how real-world data, genomics, and AI are revealing new targets and mechanisms in female-specific and reproductive conditions. Learn how data integration is shortening timelines from target identification to preclinical validation. Sharing insights into novel drug discovery approaches, the use of AI, multi-omics data, and 3D models.
A Novel Oncolytic Peptide for Triple Negative Breast Cancer Therapy
Explore the mechanism of action and preclinical efficacy of a first-in-class oncolytic peptide targeting triple negative breast cancer (TNBC). Understand how peptide-based approaches offer new hope for aggressive and treatment-refractory subtypes of breast cancer. Learn about the breast cancer therapeutic roadmap and landscape.
Bridging Clinical Development & Licensing in Women’s Health
Learn how to align clinical development strategies with licensing milestones to accelerate commercialization in women’s health. Explore what pharma and late stage investors look for in licensing-ready assets, from early efficacy signals to regulatory preparedness. Understand how to navigate clinical, legal, and market access challenges unique to women’s health to build a compelling licensing case.
Advancing Clinical Trial Design for Women’s Drugs & Devices
Sharing the role of technology and partnerships in the design & recruitment of studies. Highlighting adaptive trial designs, decentralized models, and inclusive recruitment strategies. Exploring how smarter trial design accelerates approval, reduces risk, and improves real-world outcomes.
Drug Development
Med Device
Menopause Data Advancements in Clinical Practice & Research
Discuss strategies for trial design that account for hormonal fluctuations, comorbidities, and age-related variables unique to the menopausal transition. Highlight regulatory, industry, and advocacy efforts that are pushing for menopause-specific representation in therapeutic areas beyond just women’s health. Sharing advancements to educate clinical trial patients about menopause.
Regulatory Landscape Surrounding Women’s Health Drugs & Devices
Understanding FDA approval pathways for women's health drugs and devices. Addressing regulatory gaps and challenges in clinical trial design and data collection. Strategies for working with regulators to accelerate innovation and ensure patient safety.
Drug Development
Med Device
